XML 73 R32.htm IDEA: XBRL DOCUMENT v3.22.4

Equity method investment (Tables)

12 Months Ended

Dec. 31, 2022

Equity Method Investments and Joint Ventures [Abstract]

Equity Method Investments

The following summary of BHG's financial position and results of operations as of December 31, 2022 and 2021 and for the years ended December 31, 2022, 2021 and 2020 are presented as unaudited due to BHG's fiscal year end being September 30 (in thousands):

Banker's Healthcare Group			December 31, 2022						December 31, 2021
Assets			$	4,375,643					$	2,724,542
Liabilities			$	3,821,725					$	2,355,256
Equity interests			553,918						369,286
Total liabilities and equity			$	4,375,643					$	2,724,542

			For the year ended December 31,
			2022						2021						2020
Revenues			$	1,110,230					$	735,506					$	457,928
Net income, pre-tax			$	295,186					$	241,051					$	171,964

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

+ Details

Name:	us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration